News
Scottish Biotech Transforms Whisky Waste into Sustainable Omega-3
FundingOctober 13, 2026, 9:31 pm
Scottish biotech firm MiAlgae secured £2.5M ($3.3M) from the Scottish National Investment Bank. This funding fuels a new commercial-scale facility in Grangemouth. MiAlgae innovates. It transforms whisky distilling by-products into sustainable, plant-based Omega-3 powder. This alternative to fish oil is crucial for aquaculture and pet nutrition markets. The expansion will significantly boost production. It aims to create 156 jobs by 2028. This move bolsters Scotland's circular economy. It reduces pressure on marine ecosystems. The Grangemouth site, a former refinery, becomes a green industrial hub. MiAlgae leads a vital shift towards sustainable, fish-free nutrition solutions, addressing critical global overfishing challenges.
A groundbreaking Scottish biotech company is scaling up. MiAlgae secured a significant £2.5 million ($3.3 million) investment. The Scottish National Investment Bank provided the capital. This funding targets a new commercial-scale production facility. The site is Grangemouth. This move marks a crucial step in sustainable industrial innovation.
MiAlgae pioneers a unique process. It transforms by-products from the whisky distilling industry. These waste streams become high-value ingredients. Specifically, MiAlgae produces a plant-based Omega-3 powder. This sustainable product offers a vital alternative. Traditionally, Omega-3 comes from wild-caught fish.
The demand for Omega-3 is immense. Aquaculture feed and pet nutrition sectors heavily rely on it. Omega-3 promotes healthy skin, strong coats, cognitive function, and joint health. MiAlgae’s offering is fully traceable. It supports Scotland's growing circular economy. It directly reduces global reliance on overfished marine stocks.
Global fish populations face severe threats. Nearly 90% of the world's fish stocks are fully exploited, over-exploited, or depleted. Overfishing drives a potential collapse of ocean life. Some predictions suggest this could happen by 2048. Current fish oil supplies are under intense pressure. The super El Niño phenomenon exacerbates scarcity. Supply levels are down significantly. Prices are soaring. Consumers actively seek new Omega-3 sources. MiAlgae meets this critical need.
The company's innovative approach earned international acclaim. In 2024, MiAlgae was shortlisted for The Earthshot Prize. This recognition came under the "Revive our Oceans" category. It acknowledged the company's scale-up potential and ecological impact.
The new Grangemouth facility is a game-changer. It will enable MiAlgae to produce over ten times its current Omega-3 capacity. This expansion means substantial job creation. The company projects its workforce to reach 156 people by late 2028. This injects new high-quality jobs into the Grangemouth community.
Grangemouth holds historical industrial significance. The new factory occupies the site of a former oil refinery. Petroineos closed this facility in April 2025. Its closure resulted in hundreds of job losses. MiAlgae's project is integral to the Scottish government’s Project Willow. This initiative aims to transform Grangemouth into a thriving green tech hub. The area is undergoing a significant economic regeneration.
This strategic location offers key advantages. Proximity to whisky distilleries ensures easy access to raw materials. Major customers across the UK, EU, and US are also nearby. This creates a low-carbon supply chain. MiAlgae helps pet nutrition companies worldwide reduce their environmental footprint. The plant is designed for modular scalability. This allows for rapid expansion. More sites near distilleries could follow.
The Scottish National Investment Bank is a mission-led investor. It seeks both commercial returns and societal benefits. The bank focuses on three key missions: net zero, innovation, and place. MiAlgae's investment perfectly aligns. It promotes innovative biotech solutions. It contributes to Scotland's net-zero ambitions. It revitalizes a key industrial area. This supports thriving communities.
MiAlgae's process is efficient. It feeds microalgae with nutrient-rich whisky by-products. This occurs in specially designed fermentation vessels. The microalgae naturally produce DHA, a potent Omega-3 fatty acid. After processing, the product is available in dry, wet, or supplement formats. Rigorous quality testing ensures purity. Crucially, the fermentation platform recycles whisky waste into clean water. This water returns to the watercourse.
The company's founder, Douglas Martin, established MiAlgae in 2016. It spun out of the University of Edinburgh. The university remains a steadfast supporter of MiAlgae's technological advancements. This demonstrates a strong academic-industrial partnership.
MiAlgae is not alone in this emerging field. Other startups are championing fish-free Omega-3 alternatives. Danish biotech Algiecel recently opened an industrial-scale plant. Canada’s Mara Renewables also expanded its algae-based DHA production. This growing trend underscores the urgency and potential of sustainable alternatives.
The investment builds on prior funding. MiAlgae secured £3 million from the UK government. This was part of a broader £14.5 million pledge. That pledge aims to transform Grangemouth into a low-carbon tech hub. Scotland’s £25 million Grangemouth Just Transition Fund also supports such ventures. These combined efforts cement Grangemouth's future. It becomes a leader in sustainable industrial development.
MiAlgae offers a truly circular solution. It prevents waste. It creates high-value ingredients. It protects marine ecosystems. The company is driving significant impact. It fosters a more sustainable future for global nutrition. The Grangemouth facility is a major milestone. It signals a new era for industrial biotechnology in Scotland. This move addresses pressing environmental challenges. It delivers economic growth. MiAlgae is at the forefront of this vital transformation.
A groundbreaking Scottish biotech company is scaling up. MiAlgae secured a significant £2.5 million ($3.3 million) investment. The Scottish National Investment Bank provided the capital. This funding targets a new commercial-scale production facility. The site is Grangemouth. This move marks a crucial step in sustainable industrial innovation.
MiAlgae pioneers a unique process. It transforms by-products from the whisky distilling industry. These waste streams become high-value ingredients. Specifically, MiAlgae produces a plant-based Omega-3 powder. This sustainable product offers a vital alternative. Traditionally, Omega-3 comes from wild-caught fish.
The demand for Omega-3 is immense. Aquaculture feed and pet nutrition sectors heavily rely on it. Omega-3 promotes healthy skin, strong coats, cognitive function, and joint health. MiAlgae’s offering is fully traceable. It supports Scotland's growing circular economy. It directly reduces global reliance on overfished marine stocks.
Global fish populations face severe threats. Nearly 90% of the world's fish stocks are fully exploited, over-exploited, or depleted. Overfishing drives a potential collapse of ocean life. Some predictions suggest this could happen by 2048. Current fish oil supplies are under intense pressure. The super El Niño phenomenon exacerbates scarcity. Supply levels are down significantly. Prices are soaring. Consumers actively seek new Omega-3 sources. MiAlgae meets this critical need.
The company's innovative approach earned international acclaim. In 2024, MiAlgae was shortlisted for The Earthshot Prize. This recognition came under the "Revive our Oceans" category. It acknowledged the company's scale-up potential and ecological impact.
The new Grangemouth facility is a game-changer. It will enable MiAlgae to produce over ten times its current Omega-3 capacity. This expansion means substantial job creation. The company projects its workforce to reach 156 people by late 2028. This injects new high-quality jobs into the Grangemouth community.
Grangemouth holds historical industrial significance. The new factory occupies the site of a former oil refinery. Petroineos closed this facility in April 2025. Its closure resulted in hundreds of job losses. MiAlgae's project is integral to the Scottish government’s Project Willow. This initiative aims to transform Grangemouth into a thriving green tech hub. The area is undergoing a significant economic regeneration.
This strategic location offers key advantages. Proximity to whisky distilleries ensures easy access to raw materials. Major customers across the UK, EU, and US are also nearby. This creates a low-carbon supply chain. MiAlgae helps pet nutrition companies worldwide reduce their environmental footprint. The plant is designed for modular scalability. This allows for rapid expansion. More sites near distilleries could follow.
The Scottish National Investment Bank is a mission-led investor. It seeks both commercial returns and societal benefits. The bank focuses on three key missions: net zero, innovation, and place. MiAlgae's investment perfectly aligns. It promotes innovative biotech solutions. It contributes to Scotland's net-zero ambitions. It revitalizes a key industrial area. This supports thriving communities.
MiAlgae's process is efficient. It feeds microalgae with nutrient-rich whisky by-products. This occurs in specially designed fermentation vessels. The microalgae naturally produce DHA, a potent Omega-3 fatty acid. After processing, the product is available in dry, wet, or supplement formats. Rigorous quality testing ensures purity. Crucially, the fermentation platform recycles whisky waste into clean water. This water returns to the watercourse.
The company's founder, Douglas Martin, established MiAlgae in 2016. It spun out of the University of Edinburgh. The university remains a steadfast supporter of MiAlgae's technological advancements. This demonstrates a strong academic-industrial partnership.
MiAlgae is not alone in this emerging field. Other startups are championing fish-free Omega-3 alternatives. Danish biotech Algiecel recently opened an industrial-scale plant. Canada’s Mara Renewables also expanded its algae-based DHA production. This growing trend underscores the urgency and potential of sustainable alternatives.
The investment builds on prior funding. MiAlgae secured £3 million from the UK government. This was part of a broader £14.5 million pledge. That pledge aims to transform Grangemouth into a low-carbon tech hub. Scotland’s £25 million Grangemouth Just Transition Fund also supports such ventures. These combined efforts cement Grangemouth's future. It becomes a leader in sustainable industrial development.
MiAlgae offers a truly circular solution. It prevents waste. It creates high-value ingredients. It protects marine ecosystems. The company is driving significant impact. It fosters a more sustainable future for global nutrition. The Grangemouth facility is a major milestone. It signals a new era for industrial biotechnology in Scotland. This move addresses pressing environmental challenges. It delivers economic growth. MiAlgae is at the forefront of this vital transformation.